Aptar Pharma, a subsidiary of Aptargroup, has named Jean-Marc Pardonge as the new president for the company’s prescription division.
The company is involved in developing and manufacturing nasal and pulmonary drug delivery devices.
In 2000 Pardonge served as R&D manager for Aptar Pharma’s prescription division and promoted to R&D vice president in 2003.
In January 2010, Pardonge served as global market development president for Aptar Pharma’s prescription division, where he managed and coordinated worldwide activities which included scientific and regulatory affairs, business development, communication, engineering, innovation, marketing, projects and R&D.
The market for prescription division will be leveraged with Pardonge’s knowledge in both the pharmaceutical market and the division’s customers, claims the company.
